If you need more lookups,
subscriptions start at $34 USD/month.
Matt Squires Location
Cambridge, MA, US
Matt Squires Work
VP, Global Program Head Atrasentan, Cambridge Site Head Global Development @ (September 2023 - Present)
VP, Global Program Head GI Cancer, Cambridge site head Global Drug Development @ (September 2020 - October 2023)
VP, Global Head Translational Precision Oncology @ (April 2017 - September 2020)
Ex Dir, Precision Medicine Leader - Melanoma and GU cancers @ (June 2016 - September 2020)
Sr Dir, Senior Global Correlative Science Leader @ (September 2014 - June 2016)
Dir, Global Correlative Science Lead, Oncology Clinical Development @ (September 2011 - September 2014)
Ass. Dir, Biomarker Project Leader @ (November 2010 - September 2011)
Associate Director Translational Biology @ Astex Therapeutics (June 2002 - October 2010)
Post Doc Research Associate @ Babraham Institute (September 2001 - June 2002)
Matt Squires Education
University of Leicester 1997-2000
Durham University 1994-1997
Matt Squires Skills
Clinical Development
Oncology
Drug Discovery
Biomarkers
Translational Research
Pharmaceuticals
Signal Transduction
Cancer
Translational Medicine
Personalized Medicine
Pharmacodynamics
Therapeutics
Cancer Research
Assay Development
Clinical Research
Drug Development
Biotechnology
Clinical Trials
In Vivo
Pharmaceutical Industry
Strategy
Leadership
Research
Healthcare
Validation
Life Sciences
Management
Biochemistry
Hospitals
PowerPoint
Science
Strategic Planning
Project Management
Matt Squires Summary
Matt Squires, based in Cambridge, MA, US, is currently a VP, Global Program Head Atrasentan, Cambridge Site Head Global Development at Novartis. Matt Squires brings experience from previous roles at Novartis. Matt Squires holds a 1997 - 2000 University of Leicester. With a robust skill set that includes Clinical Development, Oncology, Drug Discovery, Biomarkers, Translational Research and more. Matt Squires has 1 emails on RocketReach.
Looking for a different Matt Squires?
Find contact details for 700 million professionals.